Skip to main content

Table 2 Patient characteristics stratified by headache days per month

From: Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

Headache days per month

N

Age, mean (SD)

% Female

0–4 headache days

99

53.47 (11.53)

90.91

5–9 headache days

138

50.40 (11.07)

92.75

10–14 headache days

80

51.28 (11.51)

86.25

15–24 headache days

74

47.55 (11.27)

87.84

25–31 headache days

63

48.90 (13.30)

84.13

  1. Key: SD Standard Deviation